Paper35522720
Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 Tauopathy.
Singh G and 14 others. ACS Chem Neurosci, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 Tauopathy. Papers, record 35522720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35522720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Frontotemporal Dementia | Major topic |
| Tauopathies | Major topic |
| Animals | |
| Caspase 2 | |
| Disease Models, Animal | |
| Mice | |
| Mice, Transgenic | |
| Neurons | |
| Rats | |
| Synaptic Transmission | |
| tau Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG062199 | NIA NIH HHS | United States | R01AG062199 | PubMed and NIH | NIH RePORTER |
| RF1 AG060766 | NIA NIH HHS | United States | RF1AG060766 | PubMed and NIH | NIH RePORTER |
| R01 AG060376 | NIA NIH HHS | United States | R01AG060376 | PubMed and NIH | NIH RePORTER |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21172610 | Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. | Neuron | 2010 | https://conductscience.org/library/papers/21172610 | PubMed |
| 2 | 12798321 | Nicotinyl aspartyl ketones as inhibitors of caspase-3. | Bioorg Med Chem Lett | 2003 | https://conductscience.org/library/papers/12798321 | PubMed |
| 3 | 35059567 | Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314. | ACS Pharmacol Transl Sci | 2022 | https://conductscience.org/library/papers/35059567 | PubMed |
| 4 | 24298146 | Microtubule-associated protein tau is essential for long-term depression in the hippocampus. | Philos Trans R Soc Lond B Biol Sci | 2014 | https://conductscience.org/library/papers/24298146 | PubMed |
| 5 | 9092497 | Substrate specificities of caspase family proteases. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9092497 | PubMed |
| 6 | 7958843 | Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. | Genes Dev | 1994 | https://conductscience.org/library/papers/7958843 | PubMed |
| 7 | 28337324 | Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin. | ACS Med Chem Lett | 2017 | https://conductscience.org/library/papers/28337324 | PubMed |
| 8 | 31168644 | Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy. | Acta Neuropathol | 2019 | https://conductscience.org/library/papers/31168644 | PubMed |
| 9 | 34726479 | An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. | Science | 2021 | https://conductscience.org/library/papers/34726479 | PubMed |
| 10 | 24879153 | A nonapoptotic role for CASP2/caspase 2: modulation of autophagy. | Autophagy | 2014 | https://conductscience.org/library/papers/24879153 | PubMed |
| 11 | 30249789 | A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes. | J Neurosci | 2018 | https://conductscience.org/library/papers/30249789 | PubMed |
| 12 | 31362787 | A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease. | Acta Neuropathol Commun | 2019 | https://conductscience.org/library/papers/31362787 | PubMed |
| 13 | 20229566 | A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. | ChemMedChem | 2010 | https://conductscience.org/library/papers/20229566 | PubMed |
| 14 | 21854568 | Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease. | Mol Neurodegener | 2011 | https://conductscience.org/library/papers/21854568 | PubMed |
| 15 | 29753269 | Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease. | Curr Opin Neurobiol | 2018 | https://conductscience.org/library/papers/29753269 | PubMed |
| 16 | 24713000 | Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits. | Eur J Neurosci | 2014 | https://conductscience.org/library/papers/24713000 | PubMed |
| 17 | 32350238 | Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment. | Transl Psychiatry | 2020 | https://conductscience.org/library/papers/32350238 | PubMed |
| 18 | 32123248 | A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals. | Sci Rep | 2020 | https://conductscience.org/library/papers/32123248 | PubMed |
| 19 | 27723722 | Caspase-2 cleavage of tau reversibly impairs memory. | Nat Med | 2016 | https://conductscience.org/library/papers/27723722 | PubMed |
| 20 | 22935696 | CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis. | Cell Cycle | 2012 | https://conductscience.org/library/papers/22935696 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41486697 | In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils. | ACS Chem Neurosci | 2026 | https://conductscience.org/library/papers/41486697 | PubMed |
| 38114762 | Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer's Disease and Other Tauopathies. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38114762 | PubMed |
| 37453329 | An electrophilic fragment screening for the development of small molecules targeting caspase-2. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/37453329 | PubMed |
| 36343883 | Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias. | Transl Res | 2023 | https://conductscience.org/library/papers/36343883 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP2 | 835 | PubTator's text mining | https://conductscience.org/library/genes/835 | NCBI Gene |
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 | NCBI Gene |
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35522720
GET https://conductscience.org/api/papers/v1/35522720/references?page=2